Q: As a follow-up to my question last week about this company and based on the news this morning, has the answer changed in terms of it being fine to sell now versus still holding for a little while?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Amgen Inc. (AMGN $384.32)
-
Texas Instruments Incorporated (TXN $221.44)
-
AbbVie Inc. (ABBV $223.43)
-
Chevron Corporation (CVX $180.86)
-
Johnson & Johnson (JNJ $239.99)
-
Medtronic plc. (MDT $102.90)
-
Morgan Stanley (MS $179.96)
-
NextEra Energy Inc. (NEE $89.47)
-
PepsiCo Inc. (PEP $170.49)
-
United Parcel Service Inc. (UPS $117.34)
Q: You replied to my recent question about cdn companies paying us dividends, I would like same 5i stock screener in us companies. Your criteria was us dividends, top 25 with the largest market capitalization, 12 month trailing dividend yield, 5 yr historical dividend growth rate and anything else you may add, basically buy and forget.
Q: Hi Peter and Staff
No rush ... Happy New Year......just watched a BNN Market Call and guest tried to justify decline in his past pick JNJ by saying the numbers do not include the spinout (Kemba)? ........I held JNJ through that spin out period and never received any of the spinout. It would seem logical the price would drop after a spin out but how does that affect those who never got the spinout?
Thanks for all you do
Dennis
No rush ... Happy New Year......just watched a BNN Market Call and guest tried to justify decline in his past pick JNJ by saying the numbers do not include the spinout (Kemba)? ........I held JNJ through that spin out period and never received any of the spinout. It would seem logical the price would drop after a spin out but how does that affect those who never got the spinout?
Thanks for all you do
Dennis
-
Gilead Sciences Inc. (GILD $152.50)
-
AbbVie Inc. (ABBV $223.43)
-
Abbott Laboratories (ABT $110.83)
-
Johnson & Johnson (JNJ $239.99)
-
Eli Lilly and Company (LLY $1,058.18)
-
Merck & Company Inc. (MRK $121.93)
-
Pfizer Inc. (PFE $27.22)
-
WELL Health Technologies Corp. (WELL $4.05)
Q: Hi folks,
I am looking to replace GILD in my TFSA. I currently hold ABBV, LLY, PFE and WELL in other accounts. I am looking for a name that pays a good dividend and has some potential for growth. Can you suggest a couple of names I can take a look at or should I add one of the names I already hold.
Thanks
I am looking to replace GILD in my TFSA. I currently hold ABBV, LLY, PFE and WELL in other accounts. I am looking for a name that pays a good dividend and has some potential for growth. Can you suggest a couple of names I can take a look at or should I add one of the names I already hold.
Thanks
Q: Your thoughts on a switch from J&J to Organon in my RRSP. Income is main objective
-
Amgen Inc. (AMGN $384.32)
-
Intuitive Surgical Inc. (ISRG $488.15)
-
AbbVie Inc. (ABBV $223.43)
-
Johnson & Johnson (JNJ $239.99)
-
Eli Lilly and Company (LLY $1,058.18)
-
Medtronic plc. (MDT $102.90)
Q: Of the above health care stocks, could you rank from best to worst and indicate a good entry level for the top two. If you happen to have another better suggestion please rate accordingly.
Many thanks
Many thanks
-
Johnson & Johnson (JNJ $239.99)
-
UnitedHealth Group Incorporated (DE) (UNH $276.65)
-
Alimentation Couche-Tard Inc. (ATD $78.74)
-
Hydro One Limited (H $54.48)
Q: Hi - if inflation stays persistent and rates remain firm or a bit higher, what sectors would you favour? Has the market already identified this and they are they already outperforming? If not, what names would you recommend for purchase at their current prices?
As always, thank you for your insight.
As always, thank you for your insight.
-
AbbVie Inc. (ABBV $223.43)
-
Johnson & Johnson (JNJ $239.99)
-
Eli Lilly and Company (LLY $1,058.18)
-
Thermo Fisher Scientific Inc (TMO $542.83)
-
UnitedHealth Group Incorporated (DE) (UNH $276.65)
-
Novo Nordisk A/S (NVO $47.64)
-
iShares U.S. Medical Devices ETF (IHI $58.36)
-
iShares U.S. Healthcare Providers ETF (IHF $45.09)
Q: Hi,
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
-
Johnson & Johnson (JNJ $239.99)
-
Bank of Nova Scotia (The) (BNS $104.30)
-
Bank of Montreal (BMO $193.48)
-
BCE Inc. (BCE $34.25)
-
Enbridge Inc. (ENB $68.74)
-
Manulife Financial Corporation (MFC $51.97)
-
Canadian Imperial Bank Of Commerce (CM $132.10)
-
TC Energy Corporation (TRP $81.70)
-
Intact Financial Corporation (IFC $260.82)
-
Canadian Tire Corporation Limited Class A Non-Voting Shares (CTC.A $179.64)
-
Granite Real Estate Investment Trust (GRT.UN $88.57)
-
goeasy Ltd. (GSY $131.36)
-
Brookfield Infrastructure Partners L.P. (BIP.UN $51.94)
-
Exchange Income Corporation (EIF $98.63)
-
iShares Expanded Tech Sector ETF (IGM $125.75)
Q: I have owned these stocks for over 13 yrs incl. T, JNJ & IGM - added quite a while ago. The last 4 added last 2 years. Sitting on cash build up wondering what to do - ie. buy? Add to; ENB, GRT.UN, , GSY or ? I am 74 YY. I own in my RIF: ALA, FTS, RNW, RY, SLF, TD, RYNWH.UN and ETF ZHY. My Non- Registered account portfolio- first listed stocks represent, by far the largest portion of my investments.
-
Johnson & Johnson (JNJ $239.99)
-
Eli Lilly and Company (LLY $1,058.18)
-
Merck & Company Inc. (MRK $121.93)
Q: One gets weary of the seemingly endless legal battles that JNJ continues to suffer. I have held on to shares assuming all sides would surely give in to battle-fatigue. My assumption looks wrong, especially after yet another defeat by JNJ on Friday July 28. Worth holding or move on? As always, your opinion backed by your own reasoning would be much appreciated. If you think best trim or sell, what dividend payer in health care would you favor today (US only).
Q: Would welcome your thoughts on latest news- the litigation problem is not going away. Want to keep US healthcare exposure - what about a swap to LLY?
Q: I have a largish position in JNJ and see there is an offer to exchange some or all for a stake in KVUE at a 7% market discount which puts cost close to the IPO price of KVUE based on July 24 AM market price.
What to do - exchange some or all, ignore or buy KVUE separately rather than end up with a likely odd lot?
What to do - exchange some or all, ignore or buy KVUE separately rather than end up with a likely odd lot?
-
QUALCOMM Incorporated (QCOM $137.34)
-
AbbVie Inc. (ABBV $223.43)
-
Caterpillar Inc. (CAT $726.20)
-
International Business Machines Corporation (IBM $298.93)
-
Johnson & Johnson (JNJ $239.99)
-
Coca-Cola Company (The) (KO $79.03)
-
3M Company (MMM $172.65)
Q: Good morning. Can you please suggest your top choices for US companies with strong dividends and some growth potential.
thanks
al
thanks
al
Q: Hello,
Between these companies, if you had to buy one, which one would you prefer in this cycle and why ?
Thanks
CR
Between these companies, if you had to buy one, which one would you prefer in this cycle and why ?
Thanks
CR
-
Costco Wholesale Corporation (COST $1,001.16)
-
Microsoft Corporation (MSFT $401.14)
-
Johnson & Johnson (JNJ $239.99)
-
Morgan Stanley (MS $179.96)
Q: Hi 5i,
I plan on purchasing these 4 companies to cover off my exposure to the US markets.
What is your opinion of this portfolio? Any other addition?
Weighting in the Portfolio is a consideration, so I only have 4 positions.
Is now a good time to start accumulating, and it what order?
Thanks for the opinion.
John
I plan on purchasing these 4 companies to cover off my exposure to the US markets.
What is your opinion of this portfolio? Any other addition?
Weighting in the Portfolio is a consideration, so I only have 4 positions.
Is now a good time to start accumulating, and it what order?
Thanks for the opinion.
John
Q: Which of JNJ and GILD do you think is the better quality company for a long term investment? In response to other readers questions, you seem to like GILD, but I worry about its dependence on HIV drugs. Is it diversified enough? JNJ seems more diversified, but I worry about its talc liabilities and slow growth. Will JNJ be a stronger company after the Kenvue spin-off?
-
AbbVie Inc. (ABBV $223.43)
-
Abbott Laboratories (ABT $110.83)
-
Danaher Corporation (DHR $216.61)
-
Johnson & Johnson (JNJ $239.99)
-
Eli Lilly and Company (LLY $1,058.18)
-
Merck & Company Inc. (MRK $121.93)
-
Thermo Fisher Scientific Inc (TMO $542.83)
-
GE HealthCare Technologies Inc. (GEHC $80.65)
Q: In the US healthcare space, I am looking for a value priced name with meaningful upside total return potential (3 to 5 years) ideally with some current yield. Am thinking ABBV but not sure if I should be looking at pure play pharmaceutical, equipment mfg or..? CVS already owned
Thoughts please on above or others, and thanks
Thoughts please on above or others, and thanks
Q: What are your thoughts on NNOX? Lots of chatter about JNJ increasing stake and the stock is up significantly. Is this investable?
Q: i have the three health care stocks. i want to reduceto only .two
Which i the one i eed to let go
Which i the one i eed to let go
Q: How do current shareholders of JNJ benefit from the spinoff of Kenvue? Thank you for clarifying.